SCHEMBL7141749

SCHEMBL7141749

CO/C=C(/C(=O)O)c1ccccc1/C=C/C=C/c1cccc(F)c1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AKR1C2 P52895 1/20 0.44
NFE2L2 Q16236 7/20 0.42
AKR1C3 P42330 1/20 0.40
MAOB P27338 1/20 0.39
RELA Q04206 2/20 0.39
PTGS1 P23219 2/20 0.39
PTGS2 P35354 1/20 0.39
BCL2L1 Q07817 1/20 0.38
BAD Q92934 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
AR P10275 1/20 0.37
CYP1A1 P04798 1/20 0.37
CYP1B1 Q16678 1/20 0.37
MAPT P10636 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
GLO1 Q04760 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7141751 1.00 AKR1C2 (0.44) AKR1C2NFE2L2AKR1C3MAOBRELA
SCHEMBL7139096 0.88 MAOB (0.42) NFE2L2MAOBMEN1KMT2AAR
SCHEMBL7139094 0.88 MAOB (0.42) NFE2L2MAOBMEN1KMT2AAR
SCHEMBL7140080 0.87 TUBB4A (0.40) NFE2L2MAOBMEN1KMT2AAR
SCHEMBL7140078 0.87 TUBB4A (0.40) NFE2L2MAOBMEN1KMT2AAR
SCHEMBL7141550 0.86 MAOB (0.43) NFE2L2AKR1C3MAOBRELAMEN1
SCHEMBL7141545 0.86 MAOB (0.43) NFE2L2AKR1C3MAOBRELAMEN1
SCHEMBL7144375 0.85 MAOB (0.44) NFE2L2MAOBMEN1KMT2AMAPT
SCHEMBL7144373 0.85 MAOB (0.44) NFE2L2MAOBMEN1KMT2AMAPT
SCHEMBL7135431 0.85 NFE2L2 (0.44) NFE2L2MAOBRELAPTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0996439-B1 BETA-ALKOXYACRYLATES AGAINST MALARIA HOFFMANN LA ROCHE (CH) 2003-01-08 EP disclosed
US-6084120-A ACTIVE AGAINST CHLOROQUINE-SENSITIVE PATIENTS AND AGAINST CHLOROQUINE-RESISTANT MALARIA PATHOGENS; PROPHYLAXIS AND TREATMENT; E.G., A 3 METHOXY-2-(2-(4-PHENYLBUTA-1,3-DIEN-1-YL)PHENYL)ACRYLIC ACID HOFFMANN-LA ROCHE INC. (US) 2000-07-04 US disclosed